European Confederation of Pharmaceutical Entrepreneurs
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 06 May 2026 | Maya Matthews Head of Unit | Exchange of views on reaching out to Small and Medium Enterprises (SMEs) under the Health Technology Assessment (HTA) Regulation | SRC |
| 11 Feb 2026 | Maya Matthews Head of Unit | Exchange of views on operations under the HTA Regulation with a focus on joint clinical assessments (JCAs) | — |
| 11 Feb 2026 | Maya Matthews Head of Unit | Exchange of views on operations under the HTA Regulation with a focus on joint clinical assessments (JCAs) | SRC |
| 22 Oct 2025 | Maya Matthews Head of Unit | Exchange of views on joint clinical assessment and joint scientific consultations under the HTA Regulation. | SRC |
| 22 Oct 2025 | Maya Matthews Head of Unit | Exchange of views on joint clinical assessment and joint scientific consultations under the HTA Regulation. | — |
| 16 Oct 2025 | Laszlo Kristoffy Cabinet member | Situation of medium sized innovative pharma sector | SRC |
| 16 Oct 2025 | Olivér Várhelyi Commissioner | Situation of medium sized innovative pharma sector | — |
| 16 Oct 2025 | Olivér Várhelyi Commissioner | Situation of medium sized innovative pharma sector | SRC |
| 16 Oct 2025 | Laszlo Kristoffy Cabinet member | Situation of medium sized innovative pharma sector | — |
| 02 Oct 2025 | Jana Dabbelt Cabinet member | All pressing portfolio topics | SRC |
| 02 Oct 2025 | Olivér Várhelyi Commissioner | All pressing portfolio topics | SRC |
| 02 Oct 2025 | Jana Dabbelt Cabinet member | All pressing portfolio topics | — |
| 03 Jul 2025 | Ann-Sofie Ronnlund Cabinet member | Life sciences | SRC |
| 03 Jul 2025 | Ann-Sofie Ronnlund Cabinet member | Life sciences | — |
| 17 Jun 2025 | Olivér Várhelyi Commissioner | EU biotech policy | SRC |
| 17 Jun 2025 | Laszlo Andrejko Cabinet member | EU biotech policy | — |
| 17 Jun 2025 | Laszlo Andrejko Cabinet member | EU biotech policy | SRC |
| 17 Jun 2025 | Olivér Várhelyi Commissioner | EU biotech policy | — |
| 29 Apr 2025 | Laszlo Andrejko Cabinet member | Biotech | — |
| 29 Apr 2025 | Laszlo Andrejko Cabinet member | Biotech | SRC |
| 27 Mar 2025 | Maya Matthews Head of Unit | EU HTA regulation | SRC |
| 27 Mar 2025 | Maya Matthews Head of Unit | EU HTA regulation | — |
| 21 Nov 2024 | Marc Lemaitre Director-General | EUCOPE’s priorities and the perspective of the smaller innovative pharmaceutical industry | SRC |
| 21 Nov 2024 | Marc Lemaitre Director-General | EUCOPE’s priorities and the perspective of the smaller innovative pharmaceutical industry | — |
| 18 May 2022 | Giorgos Rossides Cabinet member | Exchange of views on the upcoming reform of the pharmaceutical legislation | — |
Mission & Goals
The European Confederation for Pharmaceutical Entrepreneurs (EUCOPE) is the voice of small to medium-sized innovative companies in the fields of pharmaceuticals, biotechnologies and medical devices. Via its member associations such as the German Pharmaceutical Industry Association (BPI), the British Ethical Medicines Industry Group (EMIG), France Biotech and the Swedish Association lif, EUCOPE represents over 2600 member companies. Corporate members include innovative family-owned companies and companies active in the field of rare diseases. EUCOPE furthers its members' scientific, technical, economic and legal objectives and represents them towards national and international governmental organisations, in particular towards the EU institutions and agencies.
EU Legislative Interests
Any legislative proposal or policy related to or affecting healthcare/public health/life sciences, in particular the general legal framework for medicinal products and medical devices as well as orphan medicinal products, substances of human origin, EU HTA and paediatrics. Industrial Strategy. Trade. The main EU legislative proposals, policies or files EUCOPE is engaged with are the below (this is not an exhaustive list): A Pharmaceutical Strategy for Europe Orphan Medicinal Products Regulation Paediatrics Regulation Directive 2001/83/EC on the Community code relating to medicinal products for human use Regulation No 726/2004 laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing a European Medicines Agency Substances of Human Origins Regulation ATMPs Regulation Clinical Trials Regulation EU Regulation on health technology assessment European Health Data Space HERA Regulation Cross-border healthcare directive Biotech Act Critical Medicines Act
Communication Activities
EUCOPE’s communication activities include: - Publishing reports on the policy areas EUCOPE is active in (e.g. reports, position papers, briefing notes, etc) on our website - Writing and publishing blogs, articles, and podcasts - Organizing events with both EUCOPE members and external stakeholders - Dissemination of EUCOPE messages through social media, external newsletters, and traditional media sources
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Kangaroo group European Policy Centre Healthcare Chain Institute
Organisation Members
http://www.eucope.org/en/eucope-members/
Connected Legislation